IMTX

Immatics N.V

• TipRanks·03/24 10:20

  Analysts Conflicted on These Healthcare Names: Siemens Healthineers AG (OtherSEMHF), Immatics (IMTX) and Aardvark Therapeutics, Inc. (AARD)

• Dow Jones·03/16 18:38

  Immatics Coverage Assumed by Jefferies at Buy

• Dow Jones·03/16 18:38

  Immatics Price Target Announced at $18.00/Share by Jefferies

• TipRanks·03/16 13:40

  Analysts Offer Insights on Healthcare Companies: LifeMD (LFMD), Immatics (IMTX) and BrightSpring Health Services, Inc. (BTSG)

• TipRanks·03/16 13:25

  Immatics assumed with a Buy at Jefferies

• Seeking Alpha·03/09 17:35

  Immatics: Buying The Anzu-Cel Floor, Playing The Moderna Moonshot

• TipRanks·03/06 14:30

  Analysts’ Top Healthcare Picks: Climb Bio (CLYM), Ibio (IBIO)

• TipRanks·03/06 13:50

  Analysts Conflicted on These Healthcare Names: Aquestive Therapeutics (AQST), Immatics (IMTX) and aTyr Pharma (ATYR)

• Seeking Alpha·03/05 21:58

  Immatics GAAP EPS of -€1.61, revenue of €48.2M

• TipRanks·03/05 17:30

  Analysts Offer Insights on Healthcare Companies: Immatics (IMTX) and Incyte (INCY)

• TipRanks·03/05 12:33

  Immatics Confirms 2027 Anzu-cel Launch Timeline as PRAME Franchise and Cash Runway Advance

• TipRanks·03/05 12:16

  Immatics sees cash runway into 2028

• TipRanks·03/05 12:07

  Immatics reports FY25 EPS (EUR 1.61) vs. EUR 0.14 last year

• NASDAQ·02/26 00:25

  Mirum Pharmaceuticals, Inc. (MIRM) Reports Q4 Loss, Tops Revenue Estimates

• TipRanks·02/10 23:30

  Immatics’ treatment of Stage II and higher CM granted FDA orphan designation